In this study we focused on determining the mechanism by which the UPR regulates VEGFA expression, as VEGFA is the best characterized stimulator of angiogenesis and represents a therapeutic target for treating cancer as well as several ischemic, infectious and inflammatory disorders [37]. This evidence concerns the gene VEGFA and cancer.